Free Trial

Navidea Biopharmaceuticals (NAVB) News Today

Navidea Biopharmaceuticals logo
$0.0010
0.00 (0.00%)
(As of 11/1/2024 ET)
Navidea Biopharmaceuticals (NYSE:NAVB) Now Covered by StockNews.com
SK Biopharmaceuticals Co. Ltd.
Suzhou Zelgen Biopharmaceuticals Co Ltd (688266)
Navidea Biopharmaceuticals, CRG Settle All Ongoing Litigation
Navidea Biopharmaceuticals Inc NAVB
Q4 2022 Navidea Biopharmaceuticals Inc Earnings Call
NAVB.PH - | Stock Price & Latest News | Reuters
Get Navidea Biopharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for NAVB and its competitors with MarketBeat's FREE daily newsletter.

Crypto Crash Ahead? (27 Experts Weigh In) (Ad)

Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you!

Click here to reserve your spot at the emergency crypto summit now.

NAVB Media Mentions By Week

NAVB Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

NAVB
News Sentiment

0.00

0.45

Average
Medical
News Sentiment

NAVB News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

NAVB Articles
This Week

2

0

NAVB Articles
Average Week

Get Navidea Biopharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for NAVB and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NYSE:NAVB) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners